Vance Thompson Vision - Omaha — Omaha, Nebraska

Vance Thompson Vision - Omaha is a clinical research site located in Omaha, Nebraska, United States 68137.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Vance Thompson Vision - Omaha has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: Fuchs Endothelial Corneal Dystrophy, Fuchs' Endothelial Dystrophy, Fuchs Dystrophy.

Sponsors: Kowa Research Institute, Inc., Trefoil Therapeutics, Inc., Bausch & Lomb Incorporated.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vance Thompson Vision - Omaha?

Vance Thompson Vision - Omaha has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vance Thompson Vision - Omaha conducted?

Vance Thompson Vision - Omaha has 5 clinical trials on record, with 1 currently active. Their work covers Fuchs Endothelial Corneal Dystrophy, Fuchs' Endothelial Dystrophy, Fuchs Dystrophy.

Is Vance Thompson Vision - Omaha accredited by Crixeo Health?

Yes — Vance Thompson Vision - Omaha holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Vance Thompson Vision - Omaha?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.